Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Can I have two surgeries at the same time? And is it a good idea?

surgeries in Hospital

Even though you may put a brave face for people around, the mere idea of lying unconscious on that operation table is too overwhelming. There are millions of questions and confusions in your mind. This is all natural. We suggest that you research your procedures, consult best professionals in the field and leave it all up to them. Things get a whole lot easier when you don’t stress yourself out.

Indeed, there are a bunch of issues that tag along with each surgery like pain, precautions and poor quality of life. However, it gets better with time.

You must know that in some cases, patients undergoing surgery are under general anesthesia. This means that they have no awareness of the procedure once the anesthesia takes effect. These are inpatient surgeries. On the other hand, there are outpatient surgeries too where there is limited use of anesthesia, and the patient can go home the same day.

We cannot always categories the surgeries according to their level of discomfort. Some people may find a particular surgery highly painful while others may not feel similar levels of pain. As per the research, orthopedic surgeries are more painful than all other types.

Then comes the question that people frequently ask online, which is, can I have two surgeries at the same time?Usually, people who plan to undergo a couple of cosmetic procedures ask this question. Or those who want to accomplish medical necessity with the cosmetic process.

You can find many debates by medical experts where some hold the stance that having multiple surgeries at the same time isn’t harmful at all. This concept is especially popular in departments of Plastic Surgery Houston. Whereas, others are strictly against such surgical procedures. They believe it puts overall patient health at risk. And this might be true in some cases.

To put things in perspective, here are a few pros and cons that we believe you should note before opting for two surgeries at once:

What are the benefits?
With advanced medicine, it has become possible for medical professionals to perform two surgeries on a patient at the same time. The appalling merits of that are:

  • Single recovery time: Recovery from any surgical procedure is usually tough. Healing takes a lot of time and disrupts the routine life of the patient. By undergoing two surgeries at once, you only have to worry about a single recovery period. Rather than twice, you will be taking time away from your family and work only once.
  • The insurance covers hospital costs: Depending on the type of medical procedures that you are going for, the insurance covers all hospital costs. It is important to note that insurance will most likely not cover cosmetic surgeries.
  • One surgery time: A single surgery time would also mean less time at the hospital in contrast to staying for two procedures separately. It would also mean undergoing anesthesia only once, which is a bliss for some people.

    What are the drawbacks?
    As we mentioned earlier, there is a large group of medical experts who are against multiple surgeries. They have their own set of beliefs, which are:
  • It is not safe: Combining some surgeries may not work in favor of the patient’s health. In fact, it may bring more risks. For instance, cosmetic surgery should not go with orthopedic surgery of lower extremities. This is because it increases the risk of DVT (blood clots).
  • Pain intensity increases: It is obvious that a person who suffers from pain at two points will be in more trouble than the one who has pain at a single part of the body. The intensity of pain multiplies if you go through two surgeries at the same time. Although you may not feel the pain at that time, once the anesthesia wears off, things may become quite unbearable.
  • Higher costs: Paying for two surgeries is going to be quite a burden for some people. Not everyone can afford to have two surgeries at the same time. If it is not medically required then waiting between two surgeries is a good idea. This gives you the time to recover, earn more, and then get back for your next procedure.

The conclusion
The safety and success of the surgery is the only reason for undergoing extreme medical procedures. If there is a chance that the results may not be as effective as a single procedure, then it is wise to drop the idea of multiple surgeries.

There is good data to suggest that combined plastic surgery operations are comparatively safe. Still, we should not be certain about anything unless a medical expert endorses that. Will it have positive outcomes from a medical standpoint? Do both surgeons work in the same facility?

To cut it short, you must discuss all your surgery plans with the professionals. Ask them to help you land on the best decision.

Who knows you might beat the odds and get back to your feet, fit and fine and ready to roll!

Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent

Micro Medical Solutions

Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced that it has received Investigational Device Exemption (IDE) approval from the U.S. FDA. IDE approval allows MMS to initiate a U.S. pivotal clinical trial to evaluate MicroStent’s safety and efficacy. MicroStent has already obtained CE Mark approval for use in the EU.

MicroStent is a vascular stent specifically designed to achieve and maintain vessel patency and improve blood flow in order to reduce below-the-knee amputations for patients with critical limb ischemia (CLI) resulting from peripheral artery disease (PAD). Last fall, MMS completed a 3-center, 15-patient feasibility study of MicroStent in which MicroStent met all primary endpoints for both safety and efficacy.

The study demonstrated in the device-related per protocol population that 90.9% of subjects had primary patency at 6 months post-index procedure, which is a composite of 90.9% subjects with freedom from occlusion, while 100% were free from a clinically driven target lesion revascularization. The study also showed 100% of subjects had freedom from the primary safety endpoint at 6 months post-index procedure, which is a composite of 100.0% subjects with freedom from death and 100% freedom from MALE (major adverse limb events) in the same population.

The FDA has granted IDE status based on these outcomes. MMS will immediately initiate the process to begin enrollment in the clinical trial, called the STAND study (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee).

“Because CLI represents the most severe clinical manifestation of PAD, we are excited to have a device that offers physicians multiple access points, as well as a trial that allows for re-intervention to effectively treat and lessen the impending limb and tissue loss,” said the study’s lead investigator, Dr. Robert E. Beasley of Mount Sinai Medical Center in Miami Beach, Florida.

Dr. Jihad A. Mustapha, an interventional cardiologist specializing in minimally invasive, non-surgical therapy for heart and peripheral vascular disease at Advanced Cardiac & Vascular Centers for Amputation Prevention in Grand Rapids, Michigan, added, “For patients with PAD, the risk of amputation is high, particularly if they have CLI. Amputees face decreased quality of life, as well as amputation-associated mortality. I look forward to the clinical trial for MicroStent because we need new solutions to help save CLI patients from amputation.”

“IDE approval for the pivotal clinical study of MicroStent is an encouraging step forward in our efforts to bring this technology to patients with CLI in the U.S. who face the potential for amputation,” Micro Medical Solutions CEO, Gregory Sullivan said. “MMS developed the  MicroStent platform in response to these patients’ needs, and we are excited to move closer to putting MicroStent in the hands of U.S. interventionalists treating CLI.”

The STAND trial (Clinical Evaluation of the MicroSTent Peripher Al Vascular SteNt in Subjects with Arterial Disease Below the Knee) is a randomized, multicenter pivotal clinical study of the MicroStent device. This important step toward FDA approval of MicroStent will include approximately 200 patients at a maximum of 25 sites across the U.S.

About Critical Limb Ischemia
Peripheral artery disease and critical limb ischemia (CLI) affect millions each year. It has been estimated that nearly 25% of CLI patients will undergo major amputation,1 and amputations due to CLI continue to escalate.2 For more information on CLI, visit www.micromedicalsolutions.net.

1. Henry AJ, Hevelone ND, Belkin M, Nguyen LL. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. J Vasc Surg. 2011 Feb;53(2):330-9.e1.

2. Baser O, Verpillat P, Gabriel S, et al. Prevalence, incidence, and outcomes of critical limb ischemia in the US Medicare population. Vasc Dis Mgmt. 2013:10;E26-36.

About Micro Medical Solutions
Micro Medical Solutions is on a mission to provide solutions to some of the most pressing unmet needs in microvascular intervention by helping to significantly reduce the rate of amputations, improve clinical outcomes and patient quality of life, and minimize the financial and human costs associated with the treatment of peripheral artery disease and critical limb ischemia. For more about Micro Medical Solutions, visit www.micromedicalsolutions.net

 

Conifer Health and Dartmouth Hitchcock Health Expand Relationship

Hitchcock Health Expand Relationship

Conifer Health Solutions announced a new revenue cycle management (RCM) agreement with Alice Peck Day Memorial Hospital (APD), a member of Dartmouth-Hitchcock Health (D-HH) based in Lebanon, New Hampshire. The addition of APD further expands the number of facilities benefitting from end-to-end RCM services that Conifer Health has provided to hospitals and clinics within the D-HH integrated health system.

“Conifer continues to elevate the strategic value of revenue cycle management by consistently delivering on key performance metrics. Their expertise helps D-HH maintain the firm financial footing to realize our vision for a sustainable health system that will serve New Englanders for generations to come,” said Dan Jantzen, chief financial officer for D-HH. “As D-HH and APD work to connect people throughout New Hampshire and Vermont to the thriving, integrated care community they expect, we rely on Conifer to deliver the high-quality patient financial experience they deserve.”

Since initiated in late 2016, the relationship between D-HH and Conifer Health has yielded important financial results for the health system including a 4.5 percent basis point improvement in operating margins and a 26 percent reduction in A/R days outstanding. Conifer Health will provide patient access, enrollment and eligibility, coding and accounts receivable management services at APD and has demonstrated their ability to enhance patient satisfaction and revenue capture, reduce denials and improve overall cash flow and operating margins across the system. APD is the second D-HH system member to adopt Conifer Health for comprehensive RCM services, following Cheshire Medical Center which engaged the company in November 2017.

“We are proud to continue our successful collaboration with Dartmouth-Hitchcock Health and to support their efforts to create stronger, more integrated relationships with member hospitals and providers throughout the region,” said Stephen M. Mooney, president and CEO of Conifer Health. “The impact of our work extends beyond improved margins, reduced costs and more efficient operations. As part of the community, we have also made a commitment to bring the highest quality service to patients and their families whenever and wherever they access care.”

About Dartmouth-Hitchcock Health
Dartmouth-Hitchcock Health (D-HH) is a nonprofit academic health system that serves a population of 1.9 million across northern New England. D-HH provides access to more than 1,500 primary care doctors and specialists in almost every area of medicine, delivering care in Lebanon, New Hampshire, at its flagship, Dartmouth-Hitchcock Medical Center; the Dartmouth-Hitchcock Norris Cotton Cancer Center, one of only 49 NCI-designated Comprehensive Cancer Centers in the nation; the Children’s Hospital at Dartmouth-Hitchcock; member hospitals in Lebanon, Keene, and New London, New Hampshire, and Windsor, Vermont, and through the Visiting Nurse and Hospice for Vermont and New Hampshire; and at 24 Dartmouth-Hitchcock clinics that provide ambulatory services across New Hampshire and Vermont. The D-HH system trains nearly 400 residents and fellows annually and performs cutting-edge basic, translational and clinical research.

About Alice Peck Day Memorial Hospital
Since 1932, Alice Peck Day Memorial Hospital (APD) has been the community hospital of the Upper Valley, delivering high-quality health care in a friendly environment where patients come first. Today, APD has more than 100,000 patient encounters from communities throughout New Hampshire and Vermont. Long-known for providing highly personalized care, APD also offers a wide range of specialized services which include orthopaedic surgery, neurosurgery, pain management, primary and family care, senior care, and women’s care. Outpatient services moved into the Multi-Specialty Clinic in the fall of 2017, continuing our commitment to improving the delivery of patient care. Through APD’s affiliation with Dartmouth-Hitchcock Health, we affirm our commitment to creating a sustainable health system to improve the lives of the people and communities we serve for generations to come.

Merit Medical’s Portfolio of VCF Solutions Continues to Grow: DiamondTOUCH Syringe and StabiliT Introducer

DiamondTOUCH Syringe

Merit Medical announced the launch of two products that enhance their complete portfolio of vertebral compression fracture (VCF) solutions: the DiamondTOUCH™ Syringe and the StabiliT® Introducer. With the addition of these innovative products, Merit expands upon its diverse spine portfolio, further establishing its commitment to minimally invasive vertebral augmentation (balloon kyphoplasty) and vertebroplasty treatments.

NEW DiamondTOUCH Syringe – simplified bone cement delivery and balloon inflation

The DiamondTOUCH Syringe is a cutting-edge dual indication 30 mL syringe that offers both simplified bone cement delivery as well as inflation and deflation of interventional devices up to 35 ATM/500 psi. A bright LCD screen with oversized time and pressure digits provides exceptional visibility and accuracy.

From precise cement delivery to balloon inflation, the enhanced design allows for the convenience and control of one-handed precise preparation paired with quick and easy release capabilities. Moreover, the DiamondTOUCH offers a 36-inch delivery line, allowing clinicians to operate the syringe away from direct radiation.

The DiamondTOUCH Syringe is compatible with Merit’s portfolio of vertebral compression fracture products including StabiliT cement delivery and Osseoflex® balloon inflation.

NEW StabiliT Introducer – now with optimized radiolucency

The new StabiliT Introducer offers easy and safe percutaneous access to bone and is fully compatible with current and future product lines, including StabiliT, STAR™, and Osseoflex. It retains established introducer lengths (10 cm and 12 cm) and tip configurations (trocar and bevel). To enhance clarity and ease of use, tip configuration and directionality are now printed directly on the handle. The new handle design optimizes radiolucency by minimizing obstruction.

The StabiliT Introducer offers a number of new features including an ergonomic handle for increased comfort and interoperative device manipulation, depth markers on the cannula to assist with intraoperative positioning, and a snap locking mechanism engineered to be more defined and stable.

Discover for yourself the new DiamondTOUCH Syringe and improved StabiliT Introducer, and explore all the ways Merit can support your spine procedures.

Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators

Heart Start Home defibrillators

Royal Philips , a global leader in health technology announced that the Center for Devices and Radiological Health (CDRH) of the FDA has approved the company’s premarket approval (PMA) application for its HeartStart OnSite defibrillator and HeartStart Home defibrillator, and the relevant supporting accessories, such as batteries and pad electrodes.

Philips’ HeartStart OnSite and HeartStart Home defibrillators are the only over-the-counter automated external defibrillators (AEDs) available to consumers in the US, while the HeartStart Home defibrillator is the only AED specifically indicated for home environments.

“We are committed to delivering high quality, innovative AEDs to provide personalized therapy to victims of sudden cardiac arrest,” said Arman Voskerchyan, Business Leader Therapeutic Care at Philips. “Premarket approval for our HeartStart OnSite and HeartStart Home defibrillators, currently the only over-the-counter AEDs available in the US, reflects the robust work of our teams that delivered the strong and extensive technical, clinical and production data included in the PMA filing for these devices.”

PMA for Philips’ HeartStart OnSite and HeartStart Home defibrillators can be found here. These devices already had FDA 510(k) clearance, but are now subject to PMA.

About Royal Philips

Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

Optum completes acquisition of DaVita Medical Group from DaVita

Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation’s leading independent medical groups, from DaVita Inc. As part of the transaction, HealthCare Partners Nevada, DaVita Medical Group’s primary care practice in southern Nevada, will become part of Intermountain Healthcare.

DaVita Medical Group joins OptumCare, which serves more than 80 health plans, and will provide quality care to a combined 16 million patients.

“We are excited to take this important step in building a next-generation comprehensive, coordinated health care organization. Together we will improve patient health and experiences while lowering costs across the continuum of care – including primary, specialty, urgent and surgical care,” said Andrew Witty, CEO of Optum.

“In joining Optum, DaVita Medical Group begins an exciting new chapter, helping physicians further advance patient care,” said Kent Thiry, Executive Chairman of DaVita Inc.

“DaVita will continue its focus on improving quality of life for patients and expanding access to integrated care in the kidney care space,” said Javier Rodriguez, CEO of DaVita Inc.

About DaVita Inc.

DaVita is a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe. The company is the largest provider of kidney care services in the U.S. and has been a leader in clinical quality and innovation for 20 years. Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage renal disease. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. As of March 31, 2019, DaVita serves 203,500 patients at 2,689 outpatient dialysis centers in the United States. The company also operates 234 outpatient dialysis centers in nine countries across the world. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more about how DaVita is leading the health care evolution.

About Optum

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 165,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group. For more information, visit www.optum.com

Mentice and Siemens Healthineers bring a virtual patient to the angio suite

Siemens angio suite

Siemens Healthineers, a leading medical technology company and Mentice AB, a world leader in simulation solutions for endovascular therapies, announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into the Artis icono angiography system from Siemens Healthineers. The VIST Virtual Patient thus becomes a fully integrated simulation solution for the angio-suite. The global partnership between the two companies will allow interventional radiologists, neuroradiologists, and cardiologists to perform vascular and cardiac interventions on a virtual patient inside the angio-suite.

“With an ever-increasing complexity of new interventional procedures, our customers strive to acquire and retain procedural skills while optimizing their performance and improving patient safety. The Artis icono angiography system equipped with a VIST® Virtual Patient will make it possible to train new interventional procedures directly in the angio room,” said Dr. Michael Scheuering, Head of Interventional Radiology at Siemens Healthineers.

“The VIST Virtual Patient integration into the Artis icono angiography system will open new opportunities for clinical teams to improve their overall performance, drive operational efficiency, and more importantly, help improve patient outcomes. By using the Artis icono system on the VIST Virtual Patient, clinicians may now explore new interventional procedure methods and experience the use of new medical devices while reducing clinical training on actual patients and eliminating exposure to radiation,” said Göran Malmberg, CEO at Mentice. “The VIST Virtual Patient provides an immersive, high-fidelity, simulation-based environment accessible right from the Artis icono system making this integration one of the most sophisticated options in the field of endovascular skills acquisition.”

Interventionalists may now perform simulated cardiac and vascular procedures by using the Artis icono controls to angulate the C-arm, move the angiography table, use the foot pedals, and review fluoroscopic images on the Artis icono screens while deploying actual medical devices in a radiation-free environment. The integrated solution will allow clinicians to perform procedures either by using Mentice’s extensive library of patient cases or by importing actual MR and CT patient data for case training and rehearsal. Transesophageal echocardiography (TEE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and fractional flow reserve (FFR) procedures are also available.

How Could A Care Home Benefit You In Retirement?

A Care Home Benefit You In Retirement

When looking into retirement, it is important to not only ensure that you are financially stable, but it is also important to ensure that you are prepared for later on in life. Whether this is installing handrails in your home or looking at care homes in London as well as up and down the UK, there are a number of options out there for you to choose from. In this article, we will be looking into how a care home could benefit you in your retirement.

24/7 Care
One of the biggest benefits of choosing a care home in your retirement is the 24/7 care that you will receive. With a number of staff members all on hand to look after you and provide you with the food that you need, you are being constantly cared for without countless chores. This can benefit you in retirement, particularly if you are suffering from joint issues as you will have the care and attention that you need to help you through everyday life.

Mental Stimulation
In addition to the 24/7 care, there is the mental stimulation of having people around you at all times. Though there is the opportunity for quiet in your own room, a number of care homes feature a communal area to encourage housemates to speak to one another. This not only has a television, but it also has other activities such as chess and puzzles for constant mental stimulation. In addition to these activities, there are a number of comfortable seating areas to encourage conversation and create a welcoming atmosphere to help you enjoy your retirement and maintain a healthy lifestyle.

Choice Of Location
In addition to the extras that you will find, you are also in complete control of the location. Because of this, you can either choose a location that is close to your home, or you can move somewhere entirely new to experience a whole different way of life in your retirement. As you begin to plan for your retirement later on in life, you can then make a conscious decision about the facilities that you want. This then allows you to begin saving to ensure that you have enough for your retirement plans as well as in the future.

Days Out
The final benefit of retirement in a care home is the days out that are planned. This is perfect for the building of relationships between you and the other residence as you begin to create memories together and form friendships. This is key to your retirement as it allows you to try new things and maintain mental stimulation throughout your time in a new care home. This is something to look into when choosing the perfect care home for you as you can see what is available as well as the reviews left by the families of other residence, allowing you to make an informed decision.

Whether you are looking to find your care home now, or you are just reviewing the options you may have in the future, there are a number of reasons that a care home could benefit you when it comes time for you to retire. Will you choose to stay in a care home?

Optimum Healthcare IT Releases Skillmarket Mobile Application

Optimum Healthcare IT

Optimum Healthcare IT, a Best in KLAS healthcare staffing and consulting services firm, announced that it has released a mobile version of their proprietary Skillmarket consultant application. The Skillmarket software platform was designed to provide end-to-end automation for the multiple processes and workflows critical to a successful electronic health record (EHR) go-live.

Skillmarket allows EHR consultants to quickly create profiles that include relevant skills, certifications, and references to be matched with upcoming go-live engagements. Once engaged with Optimum, the mobile application provides consultants with project details, travel information, notifications, and time clock functionality. Real-time geolocation capabilities let our project management teams track, coordinate, and effectively distribute our at-the-elbow consultants at a moment’s notice.

“The addition of mobile applications to our Skillmarket go-live platform will significantly enhance our ability to provide the highest levels of service to our healthcare clients,“ said Laramie Hartmann, CTO of Optimum Healthcare IT. “Optimum is changing the way that consultants interact with the company by providing them immediate access to upcoming projects on their mobile devices.”

Skillmarket is loaded with features and tools to support go-lives from start to finish. With a pool of over 4,000 highly skilled consultants, each carefully vetted and approved, clients have access to the industry’s best at-the-elbow support. For any go-live engagement, Skillmarket makes consultant recruiting, onboarding, and scheduling a seamless experience. Utilizing geolocation data, profile skill ratings, and additional metrics to minimize travel time, reduce expense, and improve both client and consultant satisfaction, Optimum can meet the demand for any project, large or small.

The Skillmarket mobile application is available for download from the Apple App Store or Google Play.

About Optimum Healthcare IT
Optimum Healthcare IT is a Best in KLAS healthcare IT staffing and consulting services firm based in Jacksonville Beach, Florida. Optimum provides world-class professional staffing services to fill any need as well as consulting services that encompass advisory, EHR implementation, training and activation, EHR optimization, community connect, managed services, enterprise resource planning, security, and ancillary services – supporting our client’s needs through the continuum of care. Our organization is led by a leadership team with extensive experience in providing expert healthcare staffing and consulting solutions to all types of organizations.

Visit www.optimumhit.com or call 1.904.373.0831 to find out how your organization can take advantage of our solution offerings.

Greiner Bio-One looks back on a solid financial year 2018

Greiner Bio-One International GmbH

Owing to continuing high demand and use of capacity in the core segments, both Greiner Bio-One and its suppliers invested significant sums in the enlargement of global production. The bulk of an investment volume of EUR 44.8 million flowed into new production facilities for existing core products. It also represents a platform for further expansion in the core area of blood collection.

In addition, the storage space available in Frickenhausen (Germany) was more than doubled. After a construction period of only a year, a new, fully automated high-bay warehouse fitted with the latest storage technology was put into operation thereby replacing the facility used to date. The warehouse is part of an extensive infrastructure project that forms the basis for greater efficiency in the material supply and logistics areas, and will be concluded in 2019 with an increase in production capacity.

Focus on further growth In spite of diffcult market circumstances, currency effects and stagnation with regard to individual key accounts and major orders, business volume achieved the level of the preceding year and profitability maintained at an excellent level – the turnover amounted to 473 million euros In particular, solid growth was achieved in the safety products area and the company gained ground in the regional markets in Southern and Eastern Europe, and South America. However, rising material and raw material prices as well as higher freight costs all served to hinder an even better business development.

“We are preparing for further growth through a significant increase in our production capacities”, Rainer Perneker, CEO Greiner Bio-One International GmbH.

The Asian region is one of Greiner Bio-One’s most important growth markets and for example, in China the company has been able to establish a solid position in the preanalytics field within the Beijing area. In October, a second major step followed with the foundation of an additional branch in Shanghai staffed by a focused and specialized team. The joint aim is to step up efforts in the biosciences market and move closer to the customers in this business segment.

The complete annual report can be found at www.greiner.com

Greiner Bio-One International GmbH

Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, BioScience and Sterilisation. As an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of custom-made design developments and production processes for the life sciences and medical sectors. In 2018, Greiner Bio-One International GmbH generated a turnover of 473 million euros and had over 2,300 employees, 27 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner AG, which is based in Kremsmünster (Austria).

1...688689690...1,124Page 689 of 1,124

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »